Ms. Nandini Piramal is the Executive Director of Piramal Enterprises and leads the Over-The-Counter (OTC) business of the company. Under Nandini's leadership, the OTC business moved up ranks, from 40 in 2008, to 7 in 2012. She played a pivotal role in Piramal Healthcare's branded generic-medicine business sale to Abbott Laboratories, at a record 30x EBITDA.
She heads the Human Resources function at Piramal Group and the Quality & Risk functions at Piramal Healthcare. She has recently initiated an HR transformation strategy, with renewed focus on service delivery, customer centricity and operational excellence.
In 2014, the World Economic Forum recognised Nandini as a 'Young Global Leader'.
Nandini is passionately involved with Piramal Foundation, the philanthropic arm of the Piramal Group. She directs the implementation strategy across Piramal Foundation Education Leadership programs, Piramal Sarvajal and Piramal Swasthya.
She graduated with BA (Hons.) Politics, Philosophy, and Economics from Oxford University, followed by an MBA from Stanford Graduate School of Business.
Chairman, Piramal Group
Vice Chairperson, Piramal Group
Executive Director, Piramal Group
Non-Executive Director, Piramal Enterprises Ltd.
Founder, Piramal Realty
Executive Director, Piramal Enterprises Ltd.
Director, Piramal Glass
Chairman, Piramal Glass Ceylon Plc.
Managing Director, Piramal Capital & Housing Finance Ltd.
CEO, Pharma Solutions, Piramal Enterprises Ltd.
CEO, Critical Care, Piramal Enterprises Ltd.
CFO, Piramal Enterprises Ltd.
Group Director - Strategic Business
CEO, Decision Resources Group
Managing Director, India Resurgence Fund (India RF)
CEO, Piramal Foundation
Group General Counsel, Piramal Group
President & Chief Human Resources Officer, Piramal Enterprises Ltd.